Colombia

Pharma

Colombia to seek compulsory license on ViiV's dolutegravir

After sparring with GSK’s ViiV Healthcare over the price of its HIV medication dolutegravir, Colombia appears to be taking matters into its own hands.

Fraiser Kansteiner Oct 4, 2023 3:00pm

Colombian plant already on import alert gets FDA warning letter

Apr 13, 2021 3:13pm

Tug-of-war over Novartis' Gleevec rights in Colombia escalates

May 26, 2016 9:09am